Breaking News Instant updates and real-time market news.

T

AT&T

$38.89

0.91 (2.40%)

, PBR

Petrobras

$14.53

-0.08 (-0.55%)

07:35
09/12/19
09/12
07:35
09/12/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Wednesday in AT&T (T), Petrobras (PBR), iQiyi (IQ), and Viavi (VIAV).

T

AT&T

$38.89

0.91 (2.40%)

PBR

Petrobras

$14.53

-0.08 (-0.55%)

IQ

iQIYI

$19.59

1.29 (7.05%)

VIAV

Viavi

$14.92

0.81 (5.74%)

  • 12

    Sep

  • 28

    Oct

T AT&T
$38.89

0.91 (2.40%)

09/11/19
WELS
09/11/19
NO CHANGE
Target $215
WELS
Market Perform
Apple focusing on presenting iPhone Pro as premium product, says Wells Fargo
Commenting on Apple's (AAPL) Tuesday event, Wells Fargo analyst Aaron Rakers notes that the company is focusing on presenting the iPhone Pro as a premium product. One of the biggest surprises was Apple's announced pricing for its Apple TV+ streaming service at $4.99/month versus Netflix (NFLX) $12.99 standard, Disney+ (DIS) $7.99, and HBO GO (T) $14.99, the analyst contends, adding that with a free 1-year Apple TV+ and Arcade subscription included with any new hardware purchase or upgrade, Apple is clearly focused on leveraging a subsidized pricing strategy to drive a user base as content expands. As Rakers thinks about the derivative read-though to his coverage of the NAND industry, the analyst believes that investors could be disappointed in Apple leaving its base NAND capacity point unchanged at 64GB. He reiterates a Market Perform rating and a $215 price target on Apple's shares.
09/10/19
OPCO
09/10/19
NO CHANGE
Target $41
OPCO
Outperform
Elliot's plan to accelerate AT&T shareowner value, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that Elliott Management sent a letter to AT&T's board of directors that it has taken a $3.2B effective ownership stake in the company and has a share price target of $60-plus by the end of 2021. Elliott's four-part plan recommends increased strategic focus, improving operational efficiencies, a formal capital allocation framework, and improved leadership, he adds. The analyst believes AT&T has the ability to increase shareholder value by continuing to focus more on higher growth segments that are in line with our shared infrastructure thesis. Horan notes the company is already implementing many of Elliott's recommendations, but believes it can be more aggressive with cost reductions and asset sales. He reiterates an Outperform rating and $41 price target on the shares.
09/10/19
LEHM
09/10/19
NO CHANGE
Target $35
LEHM
Equal Weight
AT&T price target raised to $35 from $31 at Barclays
Barclays analyst Kannan Venkateshwar raised his price target for AT&T (T) to $35 from $31 while keeping an Equal Weight rating on the shares. Activist Elliott Management is likely to have some impact on AT&T's strategic choices, with buybacks potentially being the most proximate, which should help close some of the company's valuation discount relative to Verizon Communications (VZ), Venkateshwar tells investors in a research note. However, while the analyst does not disagree with Elliott's take on the state of AT&T's business and some of its strategic choices, he believes that Elliott's "implicit assumptions driving some of its suggested solutions may be a bit too optimistic." Elliott suggests that AT&T should be more aggressive in monetizing larger assets such as DirecTV, but it is unclear who would buy this asset, adds the analyst.
09/11/19
FBCO
09/11/19
NO CHANGE
FBCO
Netflix head start unlikely dented by Apple TV+, says Credit Suisse
Credit Suisse analyst Douglas Mitchelson notes that his Netflix (NFLX) thesis already presumes increased competition in the future and Apple (AAPL) is noteworthy as it certainly has a "terrific brand and global distribution platform." However, the analyst believes Netflix's 10-year head start, scale, breath of content and customer engagement is unlikely to be dented by an Apple TV+ subscription service with a relatively light content slate and no library content. In fact, Apple TV+ looks more like an HBO (T) or Showtime than a Netflix, Hulu or Amazon Prime (AMZN), he contends, adding that he continues to believe SVOD will not be a zero sum game. Lastly, Mitchelson would expect Apple TV+ would more likely displace a runner-up than the leader.
PBR Petrobras
$14.53

-0.08 (-0.55%)

07/11/19
GSCO
07/11/19
INITIATION
Target $19.7
GSCO
Buy
Petrobras initiated with a Buy at Goldman Sachs
Goldman Sachs started Petrobras with a Buy rating and $19.70 price target. The company's improving returns and free cash flow are not fully priced in at current share levels, Goldman says.
07/08/19
SBSH
07/08/19
NO CHANGE
Target $23
SBSH
Buy
Petrobras price target raised to $23 from $20.20 at Citi
Citi analyst Pedro Medeiros raised his price target Friday afternoon on Petrobras shares to $23 from $20.20 and kept a Buy rating on the shares. The analyst believes Petrobras can expand domestic oil production by ~25% in the second half of 2019. He forecasts the stock offers ~17.5% free cash flow to equity yield by 2020.
07/11/19
07/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Microsoft (MSFT) initiated with an Outperform at Cowen. 2. Petrobras (PBR) initiated with a Buy at Goldman Sachs. 3. Navidea (NAVB) initiated with a Buy at Maxim. 4. Immunic (IMUX) initiated with a Buy at Chardan. 5. Target (TGT) was initiated with a Conviction Buy at Goldman Sachs, while Walmart (WMT), Home Depot (HD), Lowe's (LOW), and Costco (COST) were initiated with a Buy, and Bed Bath & Beyond (BBBY) was initiated with a Sell. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/19
07/11/19
INITIATION
Target $21.6

Buy
Petrobras initiated with a Buy at Goldman Sachs
As previously reported, Goldman Sachs analyst Bruno Amorim started Petrobras with a Buy rating and a price target of $21.60, saying the company is in the process of transitioning from a "turnaround" story to one of growth and cash generation. The analyst adds that "after a decade" of disappointing on production growth forecasts, Petrobras is positioned to expand its production volume by about 9% per year in the 2018-2020 period. Amorim further believes that investors will respond well to the management's efforts in selling non-core assets to reduce leverage and invest the proceeds in the offshore Santos Basin.
IQ iQIYI
$19.59

1.29 (7.05%)

09/12/19
BERN
09/12/19
UPGRADE
BERN
Market Perform
iQIYI upgraded to Market Perform from Underperform at Bernstein
08/20/19
LYON
08/20/19
DOWNGRADE
LYON
Outperform
iQIYI downgraded to Outperform from Buy at CLSA
CLSA downgraded iQIYI to Outperform from Buy and lowered its price target to $21 from $26.50.
08/20/19
FBCO
08/20/19
DOWNGRADE
FBCO
Neutral
iQIYI downgraded to Neutral from Outperform at Credit Suisse
09/12/19
BERN
09/12/19
UPGRADE
Target $18
BERN
Market Perform
Bernstein sees limited downside for iQIYI, upgrades to Market Perform
Bernstein analyst David Dai upgraded iQIYI (IQ) to Market Perform from Underperform with a price target of $18, up from $16. The company's near-term outlook and sentiment should improve, creating limited downside for the shares, Dai tells investors in a research note. The analyst sees iQIYI's near-term headwinds turning "incrementally better from here" ahead of declining content costs next year. Baidu (BIDU) should also benefit from improving profitability and reducing loss from iQIYI, says Dai. The analyst maintains a Market Perform rating on Baidu shares with a $126 price target.
VIAV Viavi
$14.92

0.81 (5.74%)

04/22/19
JPMS
04/22/19
NO CHANGE
JPMS
JPMorgan a buyer of Ciena and Lumentum into Q1 results, downgrades Sensata
JPMorgan analyst Samik Chatterjee names Ciena (CIEN) and Lumentum (LITE) his top Networking Equipment picks into the Q1 reporting season. The analyst is a buyer of both stocks into the prints. Following the rallies year-to-date, investors might need to be more selective relative to opportunities for further share price upside heading into earnings, Chatterjee tells investors in a pre-earnings research note. He believes the overall capital expenditure environment remains positive and that momentum into 5G investment spend appears to be building, particularly in North America. This is likely provide greater visibility to companies relative to their already stated full-year targets, says Chatterjee. However, with investor optimism around 5G infrastructure investment as well as the positive impact on growth from a potential U.S.-China trade deal, the analyst expects share price performances to be largely muted on the back of Q1 earnings. Nonetheless, he sees upside opportunity in both Ciena and Lumentum. Chatterjee also reinstated coverage of CommScope (COMM) and upgraded the shares to Overweight from Neutral, upgraded Viavi Solutions (VIAV) to Neutral from Underweight, and downgraded Sensata (ST) to Neutral from Overweight. A further multiple re-rating of Sensata shares appears unlikely in an environment of moderating auto production this year, contends the analyst.
08/16/19
STFL
08/16/19
NO CHANGE
Target $15
STFL
Buy
Viavi guidance appears conservative, says Stifel
Stifel analyst John Marchetti said Viavi management "struck a conservative tone" on expectations for the year, but he expects positive 2020 estimate revisions as production and field test contributions add to what he expects to be continued strong wireless and fiber test demand. While he lowered his revenue estimates on a reduced growth outlook for 3D sensing to reflect his expectation for slower Android growth given Huawei's difficulties in meeting handset shipment goals, Marchetti keeps a Buy rating and $15 price target on Viavi shares.
07/16/19
JPMS
07/16/19
NO CHANGE
JPMS
JPMorgan favors Ciena, Lumentum and Viavi into Q2 reports
JPMorgan analyst Samik Chatterjee previewed the Q2 earnings reports for the Networking Equipment/IT Hardware space. The analyst favors suppliers with greater exposure to service provider customers, as he's increasingly confident of a spending ramp towards 5G preparedness, relative to suppliers with higher than average exposure to either cable customers or cloud customers, where he believes visibility relative to timing of recovery in customer capex remains low. Chatterjee's top picks going into Q2 earnings are Ciena (CIEN), Lumentum (LITE), and Viavi (VIAV). He's cautious on Arista Networks (ANET) and F5 Networks (FFIV) due to "company-specific challenges" relative to the competitive landscape with the entry of VMware (VMW) into the application delivery controllers market.
04/22/19
04/22/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. IPG Photonics (IPGP) upgraded to Buy from Neutral at BofA/Merrill. 2. Caleres (CAL) upgraded to Buy from Hold at Needham with analyst Rick Patel saying that his recent meeting with its CEO and CFO have given him an added confidence about the FY19 EPS guidance being "achievable and likely beatable." 3. Viavi (VIAV) upgraded to Neutral from Underweight at JPMorgan with analyst Samik Chatterjee saying the "buildup of industry tailwinds" in the form of 5G network deployments as well as fiber densification and adoption of 3D Sensing should drive medium-term growth above expectations. 4. Alcoa (AA) upgraded to Buy from Hold at Gabelli. 5. Lam Research (LRCX) upgraded to Buy from Neutral at B. Riley FBR with analyst Craig Ellis saying he sees "increasingly visible recent signs" of a cyclical trough in Q1. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

03:05
10/14/19
10/14
03:05
10/14/19
03:05
General news
Asian Market Update: »

Asian Market Update:…

03:05
10/14/19
10/14
03:05
10/14/19
03:05
General news
FX Update: Currencies have opened the week in undramatic fashion »

FX Update: Currencies…

XLNX

Xilinx

$96.18

3.4 (3.66%)

, INTC

Intel

$52.06

0.95 (1.86%)

20:45
10/13/19
10/13
20:45
10/13/19
20:45
Upgrade
Xilinx, Intel rating change at Nomura Instinet »

Xilinx upgraded to Buy…

XLNX

Xilinx

$96.18

3.4 (3.66%)

INTC

Intel

$52.06

0.95 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 20

    Nov

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

19:49
10/13/19
10/13
19:49
10/13/19
19:49
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

FB

Facebook

$184.20

4.02 (2.23%)

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

TGT

Target

$111.86

1.29 (1.17%)

T

AT&T

$37.58

0.17 (0.45%)

ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

NUE

Nucor

$52.69

2.48 (4.94%)

PNR

Pentair

$37.33

1.215 (3.36%)

GWW

Grainger

$305.24

16.49 (5.71%)

K

Kellogg

$62.14

-0.27 (-0.43%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

TTWO

Take-Two

$122.42

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 18

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

IGMS

IGM Biosciences

$17.53

-0.125 (-0.71%)

19:42
10/13/19
10/13
19:42
10/13/19
19:42
Initiation
IGM Biosciences initiated at Piper Jaffray »

IGM Biosciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

19:37
10/13/19
10/13
19:37
10/13/19
19:37
Hot Stocks
LeMaitre acquires biologic patch business from Admedus »

LeMaitre Vascular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WE

We Company

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

18:37
10/13/19
10/13
18:37
10/13/19
18:37
Periodicals
SoftBank seeking control of WeWork through financing package, WSJ says »

SoftBank (SFTBY) has…

WE

We Company

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KOD

Kodiak Sciences

$18.24

1.34 (7.93%)

18:34
10/13/19
10/13
18:34
10/13/19
18:34
Hot Stocks
Kodiak Sciences announces safety, efficacy from Phase 1b study of KSI-301 »

Kodiak Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

18:29
10/13/19
10/13
18:29
10/13/19
18:29
Recommendations
Adverum Biotechnologies analyst commentary at Piper Jaffray »

Adverum '022 looking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

18:23
10/13/19
10/13
18:23
10/13/19
18:23
Hot Stocks
Adverum Biotechnologies reports additional data from Phase 1 trial of ADVM-022 »

Adverum Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$56.41

0.55 (0.98%)

18:03
10/13/19
10/13
18:03
10/13/19
18:03
Hot Stocks
ConocoPhillips announces $1.39B agreement to sell interests in Australia-West »

ConocoPhillips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

T

AT&T

$37.58

0.17 (0.45%)

, CMCSA

Comcast

$45.53

1.02 (2.29%)

17:18
10/13/19
10/13
17:18
10/13/19
17:18
On The Fly
Box Office Battle: 'Joker' stays at number 1 with another $55M »

"Box Office Battle" is…

T

AT&T

$37.58

0.17 (0.45%)

CMCSA

Comcast

$45.53

1.02 (2.29%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$58.16

0.83 (1.45%)

LGF.A

Lionsgate

$9.52

0.22 (2.37%)

LGF.B

Lionsgate

$8.97

0.19 (2.16%)

DIS

Disney

$130.08

0.73 (0.56%)

VIAB

Viacom

$23.02

0.505 (2.24%)

VIA

Viacom

$25.45

0.65 (2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

PCG

PG&E

$8.08

0.3 (3.86%)

16:48
10/13/19
10/13
16:48
10/13/19
16:48
Periodicals
PG&E turns down San Francisco's $2.5B offer to acquire assets, Reuters says »

PG&E rejected a $2.5B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

TTGT

TechTarget

$22.64

0.14 (0.62%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

16:44
10/13/19
10/13
16:44
10/13/19
16:44
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.64

0.14 (0.62%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$51.50

1.74 (3.50%)

HPE

HP Enterprise

$14.35

0.24 (1.70%)

HLF

Herbalife Nutrition

$39.07

0.51 (1.32%)

FORR

Forrester

$32.43

0.61 (1.92%)

CSCO

Cisco

$46.52

0.38 (0.82%)

CVLT

Commvault

$45.51

0.695 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

  • 29

    Oct

  • 29

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

FB

Facebook

$184.20

4.02 (2.23%)

16:43
10/13/19
10/13
16:43
10/13/19
16:43
Periodicals
Warren buying Facebook ads claiming Zuckerberg backs Trump, Bloomberg says »

Elizabeth Warren is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 30

    Oct

KBH

KB Home

$33.92

-0.15 (-0.44%)

16:43
10/13/19
10/13
16:43
10/13/19
16:43
Conference/Events
SunTrust to hold a field trip »

Field Trip with KB Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

BX

Blackstone

$47.10

0.62 (1.33%)

16:34
10/13/19
10/13
16:34
10/13/19
16:34
Periodicals
Blackstone discussed with Citadel about buying stake, WSJ reports »

Blackstone has held talks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

16:29
10/13/19
10/13
16:29
10/13/19
16:29
Periodicals
Google bars high-interest consumer loan services from app store, WSJ reports »

Google has barred…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

16:28
10/13/19
10/13
16:28
10/13/19
16:28
General news
Trump working with Congress on 'powerful' Turkey sanctions »

President Trump tweeted…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$169.06

1.255 (0.75%)

16:23
10/13/19
10/13
16:23
10/13/19
16:23
Hot Stocks
Allergan, Molecular Partners present data from Phase 3 Abicipar pegol studies »

Allergan and Molecular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$39.49

1.8 (4.78%)

, UBER

Uber

$30.09

1.19 (4.12%)

16:04
10/13/19
10/13
16:04
10/13/19
16:04
Periodicals
Lyft sues NYC over cruising time caps, Reuters reports »

Following its rival…

LYFT

Lyft

$39.49

1.8 (4.78%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 04

    Nov

  • 07

    Nov

  • 19

    Nov

GM

General Motors

$35.57

0.9 (2.60%)

15:59
10/13/19
10/13
15:59
10/13/19
15:59
Periodicals
UAW boosting strike pay as General Motor walkout continues, Reuters says »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$84.31

0.6 (0.72%)

, JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

15:49
10/13/19
10/13
15:49
10/13/19
15:49
Periodicals
Congo to start using Johnson & Johnson Ebola vaccine next month, Reuters says »

Health authorities in…

MRK

Merck

$84.31

0.6 (0.72%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HMTV

Hemisphere Media

$11.70

0.05 (0.43%)

15:48
10/13/19
10/13
15:48
10/13/19
15:48
Initiation
Hemisphere Media initiated at Wells Fargo »

Hemisphere Media…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.11

0.31 (0.87%)

15:37
10/13/19
10/13
15:37
10/13/19
15:37
Hot Stocks
Pfizer presents Phase 3 data for Abrocitinib in moderate to severe AD »

Pfizer announced complete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.